First Foundation Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.07M Buy
39,207
+905
+2% +$70.8K 0.11% 113
2025
Q1
$2.78M Sell
38,302
-1,999
-5% -$145K 0.11% 109
2024
Q4
$2.98M Sell
40,301
-626
-2% -$46.3K 0.11% 111
2024
Q3
$2.7M Buy
40,927
+31,547
+336% +$2.08M 0.1% 113
2024
Q2
$866K Buy
9,380
+471
+5% +$43.5K 0.03% 177
2024
Q1
$851K Hold
8,909
0.03% 183
2023
Q4
$679K Sell
8,909
-3,713
-29% -$283K 0.03% 199
2023
Q3
$874K Sell
12,622
-16,852
-57% -$1.17M 0.04% 185
2023
Q2
$2.78M Sell
29,474
-181,642
-86% -$17.1M 0.12% 114
2023
Q1
$17.5M Sell
211,116
-3,303
-2% -$273K 0.8% 33
2022
Q4
$16M Buy
214,419
+36,046
+20% +$2.69M 0.77% 34
2022
Q3
$14.7M Buy
178,373
+137,744
+339% +$11.4M 0.72% 39
2022
Q2
$3.86M Buy
40,629
+6,590
+19% +$627K 0.17% 85
2022
Q1
$4.01M Buy
34,039
+3,744
+12% +$441K 0.14% 89
2021
Q4
$3.93M Buy
30,295
+1,845
+6% +$239K 0.13% 90
2021
Q3
$3.22M Buy
28,450
+3,434
+14% +$389K 0.12% 99
2021
Q2
$2.59M Buy
25,016
+2,556
+11% +$265K 0.1% 120
2021
Q1
$1.88M Buy
22,460
+3,398
+18% +$284K 0.08% 138
2020
Q4
$1.74M Buy
19,062
+5,541
+41% +$505K 0.08% 139
2020
Q3
$1.08M Buy
13,521
+1,262
+10% +$101K 0.05% 171
2020
Q2
$847K Buy
12,259
+1,795
+17% +$124K 0.04% 183
2020
Q1
$658K Sell
10,464
-3,693
-26% -$232K 0.04% 200
2019
Q4
$1.1M Buy
14,157
+234
+2% +$18.2K 0.05% 172
2019
Q3
$1.02M Sell
13,923
-6,117
-31% -$449K 0.05% 163
2019
Q2
$1.23M Buy
20,040
+14,607
+269% +$899K 0.07% 157
2019
Q1
$346K Sell
5,433
-22,227
-80% -$1.42M 0.02% 250
2018
Q4
$1.41M Buy
27,660
+22,623
+449% +$1.15M 0.09% 142
2018
Q3
$292K Hold
5,037
0.02% 295
2018
Q2
$244K Sell
5,037
-75
-1% -$3.63K 0.01% 290
2018
Q1
$238K Sell
5,112
-507
-9% -$23.6K 0.01% 284
2017
Q4
$211K Buy
+5,619
New +$211K 0.01% 302
2016
Q1
Sell
-19,788
Closed -$521K 310
2015
Q4
$521K Sell
19,788
-1,854
-9% -$48.8K 0.04% 176
2015
Q3
$513K Buy
+21,642
New +$513K 0.04% 146